(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Online

2017 年 02 月 21 日 11:30 上午 - 2017 年 02 月 23 日 1:30 下午

Art of Writing a Clinical Overview

返回 Agenda

Part 3 – Preparing the Benefit-Risk Assessment and Best Practices for Clinical Overview Construction

Session Chair(s)

Diptee A. Gajjar, PHD

Diptee A. Gajjar, PHD

Intercontinental Regulatory Strategy Lead

Bristol-Myers Squibb Company, United States

  • Session 7: Continued:
    Strategies in Developing Section 5, Overview of Safety

  • Exercise

  • Session 8:
    Strategies in Developing Section 6, Benefits and Risks Conclusions

  • Session 9:
    Best Practices for Developing a Submission-ready Clinical Overview

  • Session 10:
    Other Clinical Overview Scenarios

  • Questions and Answers

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。